Trade: Bought additional 5000 MAGN,
which takes this up to my largest position.
Hopefully with anti-angiogenesis in the
spotlight after the Sugen deal, Magainin
will get a little good press. If not, I'm
willing to gamble the FDA will approve Pex.
Other items to note: Despite weakness in
NTII, I have decided to stay with my 10k
shares, watching the price erode from nearly
1 1/2 to back below a buck, on the bid, has
not been too cool, but I can see how the
private offering might put a little pressure
on it--those of us who follow NTII and are
willing to stick with it longer term may
just as well go through with a year lock up
and try and get shares from the offering.
McCamant's frequent re-iterations of that buy on
CTII, and a wildly high target price followed by
no market reaction is disappointing. I took a few
thousand of those off the table, again, for just
slightly more than what I paid (15/16) that drops
that one down to my fourth largest postition.
In order then...MAGN, CNSI, FSAGX, CTII, NTII--
all fairly large positions at or above 10k worth,
then small amounts of sibi, vlts, ctic--I don't
see those last two running any time soon.
Note, the gold fund is new--XAU is bouncing around
the bottom here at 60, this will get doubled if xau
breaks through and then really bottoms out around 50.
I have hope that 60 will hold. |
